Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stegeman

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Kidney & Blood Pressure Research|September 25, 2003
The Th1 and Th2 paradigm in ANCA-associated vasculitisJ S F Sanders, C A Stegeman, C G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?J Broekroelofs, C A Stegeman, G Navis, et al.
Clinical and Experimental Immunology|August 24, 2004
B cell epitope specificity in ANCA-associated vasculitis: does it matter?Y M van der Geld, C A Stegeman, C G M Kallenberg
Lancet (London, England)|January 13, 1996
c-ANCA as a marker of Wegener's diseaseC F Franssen, J W Tervaert, C A Stegeman, et al.
Clinical and Experimental Immunology|March 1, 1993
Serum markers of T cell activation in relapses of Wegener's granulomatosisC A Stegeman, J W Tervaert, M G Huitema, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Serum markers of T-cell activation in relapses of Wegener's granulomatosisC A Stegeman, J W Tervaert, M G Huitema, et al.
Arthritis and Rheumatism|April 1, 1994
Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et alJ W Tervaert, C A Stegeman, M G Huitema, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Non-oliguric acute renal failure associated with hepatitis EE A Verschuuren, E B Haagsma, J G Zijlstra, et al.
The New England Journal of Medicine|July 4, 1996
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study GroupC A Stegeman, J W Tervaert, P E de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 3, 2005
[Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen]I A Huisman, C A Stegeman, R O B Gans, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Kidney & Blood Pressure Research|September 25, 2003
The Th1 and Th2 paradigm in ANCA-associated vasculitisJ S F Sanders, C A Stegeman, C G M Kallenberg
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?J Broekroelofs, C A Stegeman, G Navis, et al.
Clinical and Experimental Immunology|August 24, 2004
B cell epitope specificity in ANCA-associated vasculitis: does it matter?Y M van der Geld, C A Stegeman, C G M Kallenberg
Lancet (London, England)|January 13, 1996
c-ANCA as a marker of Wegener's diseaseC F Franssen, J W Tervaert, C A Stegeman, et al.
Clinical and Experimental Immunology|March 1, 1993
Serum markers of T cell activation in relapses of Wegener's granulomatosisC A Stegeman, J W Tervaert, M G Huitema, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Serum markers of T-cell activation in relapses of Wegener's granulomatosisC A Stegeman, J W Tervaert, M G Huitema, et al.
Arthritis and Rheumatism|April 1, 1994
Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et alJ W Tervaert, C A Stegeman, M G Huitema, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Non-oliguric acute renal failure associated with hepatitis EE A Verschuuren, E B Haagsma, J G Zijlstra, et al.
The New England Journal of Medicine|July 4, 1996
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study GroupC A Stegeman, J W Tervaert, P E de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 3, 2005
[Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen]I A Huisman, C A Stegeman, R O B Gans, et al.
Pageof 11